Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance

Experimental Neurology
Jin-Liang ChenQian Xiao

Abstract

Diabetes mellitus (DM) can increase the risk of Alzheimer's disease (AD) in patients. However, no effective approaches are available to prevent its progression and development. Recently, autophagy dysfunction was identified to be involved in the pathogenesis of neurodegenerative diseases. This study was designed to investigate the effect of metformin on hyperphosphorylated tau proteins in diabetic encephalopathy (DE) by regulating autophagy clearance. db/db mice were randomly divided into four groups, db/+ mice were used as control group. Twelve-week old male db/db mice received consecutive intraperitoneal injection of 200 mg/kg/d metformin or (and) 10 mg/kg/d chloroquine for eight weeks. Morris water maze (MWM) tests were performed to test cognitive functions before the mice were euthanized. Metformin attenuated cognitive impairment in db/db mice, reduced hyperphosphorylated tau proteins, restored the impaired autophagy in diabetic mice, all of which were reversed by inhibiting of autophagy activity. In high glucose-cultured HT22 cells, metformin increased autophagy in a dose-dependent manner. Besides, metformin enhanced autophagy activity in an AMPK dependent manner. These data show that metformin may reduce tauopathy and imp...Continue Reading

Citations

Jan 25, 2019·British Journal of Pharmacology·Judit M Perez Ortiz, Russell H Swerdlow
May 28, 2019·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Devin WahlDavid G Le Couteur
Mar 15, 2020·Brain and Behavior·Jalaja MadhusudhananVasudharani Devanathan
Nov 22, 2019·Reviews in the Neurosciences·Bor Luen Tang
Jun 17, 2020·Expert Opinion on Drug Discovery·Dasol KimHo Jeong Kwon
Dec 11, 2019·Drug Development Research·Kavya JashKiran Kalia
Jun 2, 2020·Frontiers in Endocrinology·Claudio Daniel GonzalezMaria Ines Vaccaro
Mar 10, 2020·BioMed Research International·Brhane Teklebrhan AssefaMeles Tekie Gidey
Mar 21, 2019·World Journal of Diabetes·Eleni XourgiaAndreas Melidonis
Jan 15, 2020·Current Neuropharmacology·Yuan ZhaoGuofeng Yang
Feb 11, 2021·Alzheimer's Research & Therapy·Yanxing ChenBaorong Zhang
Feb 16, 2021·Frontiers in Pharmacology·Bo Bai, Haibo Chen
Feb 2, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Guangli LuChuning Zhang
Oct 13, 2019·Current Medicinal Chemistry·Agnieszka JankowskaGrażyna Chłoń-Rzepa
Jul 25, 2021·International Journal of Molecular Sciences·Tadanori HamanoYasunari Nakamoto
Oct 12, 2021·Expert Opinion on Drug Metabolism & Toxicology·Natalie R NeumannVasilis Vasiliou
Oct 23, 2021·The European Journal of Neuroscience·Xiao-Yu LiuPing Xu
Dec 24, 2021·Expert Opinion on Investigational Drugs·Andreas P KatsenosKonstantinos I Tsamis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.